Form SEC STAFF ACTION Panbela Therapeutics,
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ligand prices $625M convertible notes due 2031 at 0% interest
- TaskUs names Rishabh Khemka as CFO, effective June 2026
- Deep Fission raises $40M in public offering on Nasdaq
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
